Printed From BioPortfolio.com
Nerlynx Modestly Improves Survival of HER 2-Positive Early Stage Breast Cancer
20:01 EDT 31 Oct 2017 | Cancer Connect
Positive results from the clinical trial evaluating neratinib for the extended adjuvant treatment of early stage HER2-positive breast cancer following […]
The post Nerlynx Modestly Improves Survival of HER 2-Positive Early Stage Breast Cancer appeared first on .
Original Article: Nerlynx Modestly Improves Survival of HER 2-Positive Early Stage Breast Cancer
